- Home
- AVDL vs REAX Comparison
AVDL vs REAX Comparison
Compare AVDL & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- REAX
- Stock Information
- Founded
- AVDL 2015
- REAX 2018
- Country
- AVDL Ireland
- REAX United States
- Employees
- AVDL N/A
- REAX N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- REAX
- Sector
- AVDL Health Care
- REAX
- Exchange
- AVDL Nasdaq
- REAX Nasdaq
- Market Cap
- AVDL 993.5M
- REAX 1.1B
- IPO Year
- AVDL 1996
- REAX N/A
- Fundamental
- Price
- AVDL $10.34
- REAX $4.72
- Analyst Decision
- AVDL Strong Buy
- REAX Strong Buy
- Analyst Count
- AVDL 6
- REAX 3
- Target Price
- AVDL $24.00
- REAX $5.50
- AVG Volume (30 Days)
- AVDL 1.1M
- REAX 766.0K
- Earning Date
- AVDL 11-12-2024
- REAX 11-07-2024
- Dividend Yield
- AVDL N/A
- REAX N/A
- EPS Growth
- AVDL N/A
- REAX N/A
- EPS
- AVDL N/A
- REAX N/A
- Revenue
- AVDL $138,160,000.00
- REAX $1,095,350,000.00
- Revenue This Year
- AVDL $523.86
- REAX $79.06
- Revenue Next Year
- AVDL $70.46
- REAX $30.06
- P/E Ratio
- AVDL N/A
- REAX N/A
- Revenue Growth
- AVDL 1523.50
- REAX 81.37
- 52 Week Low
- AVDL $9.41
- REAX $1.52
- 52 Week High
- AVDL $19.09
- REAX $6.75
- Technical
- Relative Strength Index (RSI)
- AVDL 46.37
- REAX 42.19
- Support Level
- AVDL $9.97
- REAX $4.44
- Resistance Level
- AVDL $10.53
- REAX $4.92
- Average True Range (ATR)
- AVDL 0.47
- REAX 0.24
- MACD
- AVDL 0.12
- REAX -0.02
- Stochastic Oscillator
- AVDL 61.43
- REAX 35.06
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm. It has developed, integrated, and adopted various mobile and desktop-focused technologies to create a comprehensive offering to its agents and to assist Real with its brokerage operations. The group delivers a cloud-based platform to improve efficiencies and empower real estate agents to provide a seamless end-to-end experience for homebuyers and sellers. The company generates its maximum revenue from the United States.